COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 728: Articles 7271-7280  | Next

SARS-CoV-2 3CLpro mutations confer resistance to Paxlovid (nirmatrelvir/ritonavir) in a VSV-based, non-gain-of-function system
Heilmann, E., Costacurta, F., Volland, A., von Laer, D.
10.1101/2022.07.02.495455 — Posted: 2022-07-04
Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines
Kaplonek, P., Deng, Y., Lee, J. S.-L., Zar, H., Zavadska, D., Johnson, M., Lauffenburger, D. A., Goldblatt, D., Alter, G.
10.1101/2022.06.28.22276786 — Posted: 2022-07-04
estimateR: An R package to estimate and monitor the effective reproductive number
Scire, J., Huisman, J. S., Grosu, A., Angst, D. C., Li, J., Maathuis, M. H., Bonhoeffer, S., Stadler, T.
10.1101/2022.06.30.22277095 — Posted: 2022-07-03
Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation
Abell, I. R., McCaw, J. M., Baker, C. M.
10.1101/2022.06.30.22277126 — Posted: 2022-07-03
Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2
Voutouria, C., Hardin, C. C., Naranbhai, V., Nikmaneshia, M. R., Khandekar, M. J., Gainor, J. F., Stylianopoulosb, T., Munn, L. L., Jain, R. K.
10.1101/2022.06.30.22277076 — Posted: 2022-07-03
Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial
Raabe, V. N., Fleming, A., Samanovic, M. I., Lai, L., Belli, H. M., Mulligan, M. J., Belmont, H. M.
10.1101/2022.07.01.22277058 — Posted: 2022-07-03
Impact of SARS-Cov-2 on Clinical Trial Unit workforce in the United Kingdom; An observational study
Delanerolle, G., Hu, J., Cavalini, H., Yardley, L., Barnard-Kelly, K., Elliot, K., Raymont, V., Rathod, S., Shi, J. Q., Phiri, P.
10.1101/2022.06.30.22277052 — Posted: 2022-07-03
MENTAL STATUS OVERVIEW IN THE ELDERLY DURING THE COVID-19 PANDEMIC: A PHYLOSOPHICAL PERSPECTIVE
Andriani, A., Lio, F., Saleh, A., Fiqri, A. M.
10.1101/2022.06.30.22277080 — Posted: 2022-07-03
Online grocery shopping during the COVID-19 pandemic - perspectives of adolescents and young adults
Brandt, E. J., Hadler, N., Locher, I., Hoffs, C. T., Waselewski, M. E., Chang, T.
10.1101/2022.06.30.22277101 — Posted: 2022-07-03
Multiple effects of TNFα inhibitors on the development of the adaptive immune response after SARS-CoV-2 vaccination
Geisen, U. M., Rose, R., Neumann, F., Ciripoi, M., Vullriede, L., Reid, H. M., Berner, D. K., Bertoglio, F., Hoff, P., Hust, M., Longardt, A. C., Lorentz, T., Rios Martini, G., Saggau, C., Schirmer, J. H., Schubert, M., Suembuel, M., Tran, F., Voss, M., Zeuner, R., Morrison, P. J., Bacher, P., Fickenscher, H., Gerdes, S., Peipp, M., Schreiber, S., Krumbholz, A., Hoyer, B. F.
10.1101/2022.07.01.22277143 — Posted: 2022-07-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).